CGP 28014

Known as: CGP-28014 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND AND PURPOSE Catechol-O-methyltransferase (COMT) inhibitors are used in Parkinson's disease in which pain is an… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
1994
Review
1994
1. The structure of catechol O-methyltransferase (COMT) has been recently characterized and a series of new and selective COMT… (More)
Is this relevant?
1994
1994
1. Effects of two new inhibitors of catechol O-methylation (CGP 28014 and entacapone; 30 mg kg-1, i.p.) were compared by means of… (More)
Is this relevant?
1993
1993
The effects on rat striatal dopamine (DA) metabolism of systemic and local administration of CGP 28014, an inhibitor of catechol… (More)
  • figure 1
  • table I
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
1993
1993
The effects of three new, selective inhibitors of catechol O-methylation were compared regarding their potentiation of L-3,4… (More)
Is this relevant?
1992
1992
1. We compared three new catechol O-methyltransferase (COMT) inhibitors (OR-611, Ro 40-7592 and CGP 28014; 10 and 30 mg kg-1, i.p… (More)
Is this relevant?
1990
1990
CGP 28014 (N-(2-pyridone-6-yl)-N′,N′-di-n-propylformamidine) or its methanesulfonate salt CGP 28014 A was suspected to be a… (More)
  • figure 3
  • figure 2
  • table 1
  • figure 4
  • figure 5
Is this relevant?
1990
1990
CGP 28014 A is a specific inhibitor of catechol-O-methyl transferase (COMT). The effect on COMT was assessed with the levodopa… (More)
Is this relevant?
1990
1990
Methods potentially suitable for the determination of the COMT inhibitory properties of CGP 28014 (N-(2-pyridone-6-yl)-N',N'-di-n… (More)
Is this relevant?